Dr Lal Pathlabs Ltd

Dr Lal Pathlabs | 539524

Market Closed

₹3,264.90

+₹0.00 (+2.59%)

As on 19/11/25, 11:07 AM

Market Cap26,662.39 CR

Current Price₹3,264.9

High / Low₹3,540 / 2,293.55

PE Ratio42.52

Book Value₹259.92

Dividend Yield0.97%

ROCE29.23%

ROE24.65%

Face Value₹2.00

Current Vol.56,968

Average Vol.12,76,53,456

ISININE600L01024

PB Ratio9.53

Debt to Equity0.1

Net Profit Margin20

Operating Margin32.06

Stock cgart

Stock Performance

₹2,480₹2,490

₹2,500

Previous CloseToday's Open

₹1,800₹3,000

₹2,500

52W Low52W High

₹2,480Today's Open

₹2,490Previous Close

12,00,000Volume

₹1,80052W Low

₹3,00052W High

Ratios

No data available

About Company

Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr
Lal PathLabs Private Limited', on February 14, 1995 at Delhi
The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company
The Company converted into a Public Limited Company and name of the Company was changed to Dr
Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015
Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres
Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions
Presently, the Company is engaged the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations
The Company has built a national, 'hub and spoke' network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 371 other clinical laboratories, 5,102 patient service centers and 10,938 pickup points as of 31 March 2023
Its customers include individual patients, hospitals and other healthcare providers and corporate customers

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

;

Technical Indicators

RSI54.29

SMA 203121.95

SMA 503178.06

SMA 1003136.93

SMA 2002921.43

SMA 103123.03

MACD_12_26_Days-4.89

EMA10Day3136.87

EMA20Day3135.14

EMA50Day3149.88

MACD_12_26_9_Days10.62

EMA100Day3112.55

EMA200Day3022.27

Pivot Points

Volume Analysis

Growth Rate

Revenue Growth10.54%

ROE24.48%

EBITDA Margin32.06%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	2,461.40	2,226.64	2,016.88	2,087.41	1,581.27
Interest	22.31	29.36	37.53	30.18	16.00
Expenses	1,765.80	1,617.40	1,527.05	1,526.68	1,144.99
Financing Profit	789.03	678.41	531.55	613.27	487.61
Financing Margin %	32%	30%	26%	29%	31%
Other Income	93.43	69.17	41.72	52.55	51.33
Depreciation	141.92	143.60	150.19	108.11	77.20
Profit before tax	624.80	505.45	343.83	474.98	394.41
Tax %	21%	28%	30%	26%	25%
Net Profit	492.25	362.29	241.08	350.29	296.48
EPS in Rs	58.48	43.05	28.82	41.70	35.33

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
GOLDMAN SACHS BANK EUROPE SE - ODI	20 Oct ‘25	Purchase	33,414	₹3,160	51.05%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	20 Oct ‘25	Sell	33,414	₹3,160	51.05%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	03 Oct ‘22	Sell	45,068	₹2,518.75	16.76%
ISHARES CORE MSCI EMERGING MARKETS ETF	03 Oct ‘22	Purchase	45,068	₹2,518.75	16.76%
ISHARES INDIA SC MAURITIUS COMPANY	03 Oct ‘22	Sell	8,417	₹2,518.75	3.13%
ISHARES MSCI INDIA SMALL-CAP ETF	03 Oct ‘22	Purchase	8,417	₹2,518.75	3.13%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

07 Nov 2025

Interim 2 Dividend (₹7)

Declaration of 2nd Interim Dividend of INR 7/- per equity share (@ 70% on a face value of INR 10/- each) for the financial year 2025-26. The record date for the purpose of payment of Interim Dividend shall be November 7, 2025.

31 Oct 2025

06 Aug 2025

Interim Dividend (₹6)

Decleration of Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2025-26. The record date for the purpose of payment of Interim Dividend shall be August 06, 2025

31 Jul 2025

28 Jun 2025

AGM

25 Apr 2025

06 Jun 2025

Final Dividend (₹6)

Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at ensuing Annual General Meeting ('AGM'). The record date for the purpose of payment of final dividend shall be June 06, 2025. The Final Dividend will be dispatched/ credited within 30 days of the approval by the Members.

25 Apr 2025

06 Feb 2025

EGM

06 Feb 2025

05 Feb 2025

Interim 3 Dividend (₹6)

Approved declaration of 3rd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the FY 2024-25. The record date for the purpose of payment of 3 rd Interim Dividend shall be February 05, 2025. The 3rd Interim Dividend will be dispatched/ credited within 30 days of the declaration.

30 Jan 2025

05 Nov 2024

Interim 2 Dividend (₹6)

Board of Directors in their meeting held today i.e. October 23, 2024 interalia considered & approved the following(s): Declaration of 2nd Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date for the purpose of payment of 2nd Interim Dividend shall be November 5, 2024. The 2nd Interim Dividend will be credited/ dispatched within 30 days of its declaration.

23 Oct 2024

20 Aug 2024

Interim Dividend (₹6)

Outcome of Board Meeting held on August 7, 2024 Declaration of Interim Dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year 2024-25. The record date for the purpose of payment of Interim Dividend shall be August 20, 2024.

07 Aug 2024

29 Jun 2024

AGM

10 May 2024

10 Jun 2024

Final Dividend (₹6)

Recommendation of final dividend of INR 6/- per equity share (@ 60% on a face value of INR 10/- each) for the financial year ended March 31, 2024 subject to approval of the Shareholders at ensuing Annual General Meeting ('AGM') of the Company. The record date for the purpose of payment of final dividend shall be June 10, 2024.

10 May 2024

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
3,180	26,641	50	11	39	0	20.00%
1,118	1,08,720	77	11	60	0	15.31%
7,384	1,06,173	64	12	42	1	6.91%
928	70,037	70	7	50	0	9.98%
1,949	39,827	47	10	34	1	14.42%
680	35,217	95	8	56	0	7.26%
1,190	31,990	54	9	40	0	13.04%
668	26,737	81	12	49	1	13.67%
643	25,901	55	5	28	0	13.62%
1,898	19,241	53	7	43	0	20.28%

Showing 10 of 56 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

Frequently Asked Questions

What is Share Price of Dr Lal Pathlabs Ltd?

The current share price of Dr Lal Pathlabs Ltd (Dr Lal Pathlabs) is ₹3264.90. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Dr Lal Pathlabs Ltd?

The Price-to-Earnings (P/E) ratio of Dr Lal Pathlabs Ltd is 3264.90. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd has a 52-week high of ₹3540.00 and a 52-week low of ₹2293.55. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd offers a dividend yield of 0.75%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Dr Lal Pathlabs Ltd?

The Earnings Per Share (EPS) of Dr Lal Pathlabs Ltd is ₹63.78. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd has a Return on Equity (ROE) of 24.65%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds.